Lv0
0 积分 2021-04-06 加入
Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective
2天前
已完结
Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
2天前
已完结
Apatinib in combination with docetaxel and S‐1 chemotherapy as first‐line treatment for metastatic gastric cancer
2天前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
1年前
已完结
皖公网安备34019202002308
